Exocrine pancreas function decreases during the progression of the beta-cell damaging process in young prediabetic
Anita Kondrashova1, Noora Nurminen1, Jussi Lehtonen1
1Department of Virology, School of Medicine, University of Tampere, Tampere, Finland.
Insights
Exocrine pancreas dysfunction in type 1 diabetes develops after islet autoimmunity begins. Elastase-1 levels, a marker of exocrine function, were normal at autoantibody appearance but low at diabetes diagnosis.
Area of Science:
- Endocrinology
- Gastroenterology
- Immunology
Background:
- Type 1 diabetes is associated with decreased exocrine pancreas function.
- The timing of this exocrine dysfunction relative to the onset of islet autoimmunity is unclear.
Purpose of the Study:
- To investigate when exocrine pancreas dysfunction manifests in relation to islet autoimmunity in type 1 diabetes.
- To determine if reduced exocrine function develops after the initiation of islet autoimmunity.
Main Methods:
- The study utilized data from the prospective Type 1 Diabetes Prediction and Prevention study.
- Elastase-1 levels were measured in stool samples from children at autoantibody seroconversion and diabetes diagnosis, compared to age-matched controls.
Main Results:
- Elastase-1 levels were significantly lower in children with type 1 diabetes at diagnosis compared to controls.
- No significant difference in elastase-1 levels was observed between cases and controls at the time of autoantibody positivity.
Conclusions:
- Exocrine pancreas dysfunction appears to develop after the onset of islet autoimmunity.
- Further research is needed to explore the predictive value of reduced elastase levels for type 1 diabetes progression.
Objective:
The function of the exocrine pancreas is decreased in patients with type 1 diabetes but it is not known when this defect develops. The current study set out to determine whether the reduced exocrine function becomes manifest after the initiation of islet autoimmunity.
Methods:
The study was nested in the prospective Type 1 Diabetes Prediction and Prevention study where children with human leukocyte antigen (HLA)-conferred susceptibility are observed from birth. Elastase-1 levels were analyzed from stool samples collected at the time of seroconversion to islet autoantibody positivity and at diagnosis of type 1 diabetes, as well as from samples taken from matched control children of similar age.
Results:
Elastase levels were lower in case children at the time of the diagnosis of diabetes when compared to the control children. However, elastase concentrations did not differ between cases and controls at the time when autoantibodies appeared.
Conclusion:
The results suggest that the defect in the exocrine function develops after the appearance of islet autoantibodies. Further studies are needed to assess whether reduced elastase levels predict rapid progression of islet autoimmunity to clinical disease.
Related Concept Videos
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Insulin Secretory Vesicles
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...


